title: Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea.
abstract: Human enterovirus 71 (EV 71) has caused large-scale outbreaks of hand-foot-and-mouth disease (HFMD), particularly in the Asian-Pacific region. In this study, we report a major outbreak of EV 71 infection in Korea and describe the clinical differences between EV 71 and non-EV 71 enterovirus infections. We prospectively enrolled patients with suspected viral infections during a recent 2-year period through a nationwide surveillance system. We identified 719 patients with suspected HFMD or herpangina using real-time PCR and genotyping based on VP1 sequence analysis. The major pathogen causing HFMD changed substantially from 2008 to 2009, with EV 71 becoming the most common cause of HFMD in Korea in 2009. We successfully identified the enteroviral genotypes for 218 of the 719 patients. Patients with EV 71 infections tended to be younger than those with non-EV 71 enteroviral infections and presented with HFMD and meningoencephalitis. In addition, the occurrence of fever, headache, and neck stiffness was significantly higher in patients with EV 71 infections. Multivariable analysis showed that for patients presenting with HFMD, fever, or a sore throat, each covariate was independently associated with EV 71 infection; the adjusted odds ratios (with 95% confidence intervals in parentheses) for these variables were 31.86 (10.04 to 101.09), 4.76 (1.71 to 13.25), and 0.18 (0.04 to 0.77), respectively. Our results indicate that EV 71 was a major cause of HFMD in Korea during the study period. In addition, we found that clinical symptoms may be helpful in the early identification of patients with EV 71 infections.
authors.affiliation: Division of Enteric and Hepatitis Viruses, National Institute of Health, Korea Center for Disease Control and Prevention, Seoul, Republic of Korea.
authors.forename: Wi-Sun
authors.initials: WS
authors.lastname: Ryu
authors.forename: Byounghak
authors.initials: B
authors.lastname: Kang
authors.forename: Jiyoung
authors.initials: J
authors.lastname: Hong
authors.forename: Seoyeon
authors.initials: S
authors.lastname: Hwang
authors.forename: Jonghyun
authors.initials: J
authors.lastname: Kim
authors.forename: Doo-Sung
authors.initials: DS
authors.lastname: Cheon
mesh_terms: D000704:Analysis of Variance; D002648:Child; D002675:Child, Preschool; D003384:Coxsackievirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000821:virology; D029821:Enterovirus A, Human / Q000235:genetics*; D005260:Female; D005838:Genotype; D005843:Geography; D006232:Hand, Foot and Mouth Disease; D006557:Herpangina; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D056910:Republic of Korea / Q000453:epidemiology; D020133:Reverse Transcriptase Polymerase Chain Reaction
references.citation: J Med Virol. 2009 Feb;81(2):317-24
references.pmid: 19107980
references.citation: Pediatr Int. 2006 Jun;48(3):250-6
references.pmid: 16732789
references.citation: Clin Infect Dis. 1999 Jul;29(1):184-90
references.pmid: 10433583
references.citation: Neurology. 2003 May 27;60(10):1651-6
references.pmid: 12771257
references.citation: Pediatrics. 2002 Jun;109(6):e88
references.pmid: 12042582
references.citation: N Engl J Med. 1999 Sep 23;341(13):929-35
references.pmid: 10498487
references.citation: Virus Res. 2008 Nov;137(2):206-12
references.pmid: 18706461
references.citation: J Neurovirol. 2003 Feb;9(1):126-8
references.pmid: 12587076
references.citation: Pediatr Infect Dis J. 1999 Dec;18(12):1033-9; quiz 1040
references.pmid: 10608620
references.citation: N Engl J Med. 1999 Sep 23;341(13):936-42
references.pmid: 10498488
references.citation: FEMS Microbiol Rev. 2002 Mar;26(1):91-107
references.pmid: 12007645
references.citation: Arch Virol. 2003 Jul;148(7):1369-85
references.pmid: 12827466
references.citation: Microbiol Immunol. 2002;46(9):621-7
references.pmid: 12437029
references.citation: Virol J. 2009 Jul 07;6:95
references.pmid: 19583870
references.citation: J Med Virol. 2002 Jun;67(2):217-23
references.pmid: 11992582
references.citation: Clin Infect Dis. 2001 Jan 15;32(2):236-42
references.pmid: 11170913
references.citation: Clin Infect Dis. 2000 Sep;31(3):678-83
references.pmid: 11017815
references.citation: Clin Microbiol Infect. 2007 Jul;13(7):677-82
references.pmid: 17441979
references.citation: J Contam Hydrol. 2003 Mar;61(1-4):117-29
references.pmid: 12598099
references.citation: Clin Infect Dis. 2004 Jun 15;38(12):1784-8
references.pmid: 15227628
references.citation: Emerg Infect Dis. 2003 Mar;9(3):291-3
references.pmid: 12643822
references.citation: Emerg Infect Dis. 2009 Jan;15(1):79-82
references.pmid: 19116058
references.citation: J Clin Virol. 2009 Apr;44(4):262-7
references.pmid: 19269888
references.citation: Clin Infect Dis. 2007 Mar 1;44(5):646-56
references.pmid: 17278054
references.citation: J Clin Microbiol. 2009 Jul;47(7):2351-2
references.pmid: 19439545
references.citation: Emerg Infect Dis. 2007 Nov;13(11):1733-41
references.pmid: 18217559
references.citation: Lancet. 2000 Oct 14;356(9238):1338
references.pmid: 11073035
references.citation: Arch Virol. 2009;154(7):1139-42
references.pmid: 19506798
references.citation: J Clin Microbiol. 2006 Aug;44(8):2698-704
references.pmid: 16891480
references.citation: J Clin Microbiol. 2009 Nov;47(11):3653-62
references.pmid: 19776232
references.citation: J Clin Microbiol. 2001 Nov;39(11):4093-6
references.pmid: 11682535
references.citation: J Infect Dis. 2001 Mar 15;183(6):850-6
references.pmid: 11237800